Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
With trial win, Merck looks to take on Sanofi, AZ in RSV
A trial of Merck's preventive RSV antibody scored on several endpoints, showing an ability to protect infants from the virus.
Kevin Dunleavy
Oct 17, 2024 6:00pm
Merck signs $1.9B deal to explore fibroblast therapies
Oct 8, 2024 8:55am
Biopharma layoff rate stabilizes in Q3: Fierce Biotech analysis
Oct 4, 2024 3:50pm
Big Pharma backers return for Aktis' $175M series B
Sep 30, 2024 8:00am
Merck bags options on Evaxion's AI-designed vaccine candidates
Sep 26, 2024 7:30am
2 cancer biotechs merge, creating global footprint
Sep 25, 2024 10:54am